Skip to content

Vitoss BA2X 2102-2110Recalls & reported problems

Stryker Corporation · Bioactive Bone Graft Substitute, Foam Pack; Beta-Tricalcium Phosphate, Type I Bovine Collagen, and Bioactive Glass · Class 2 · Implant

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00808232000702), received between Apr 21, 2023 and Apr 21, 2023 — classified as 1 injury.

The most frequently reported specific device problem is “Migration” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Migration1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryApr 21, 2023Migration; Migration

    A COMPANY REPRESENTATIVE REPORTED THAT A 10 CC UNIT OF VITOSS BA2X FOAM MIGRATED INTO THE SOFT TISSUE IN THE PATIENT'S HEEL POST-OPERATIVELY. THE PHYSICIAN, "NUMBED [THE PATIENT] UP IN THE OFFICE, OPENED IT, AND CLEANED 90% OF IT OUT."

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 16791592 ↗

Other FILLER, BONE VOID, CALCIUM COMPOUND devices

All FILLER, BONE VOID, CALCIUM COMPOUND devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.